Taiko Pharmaceutical News

Taiko Pharmaceutical: Confirmation letter

May 10 02:37 ET

Taiko Pharmaceutical: Quarterly Report - 79th Quarter 1 (2024/01/01 to 2024/03/31)

May 10 02:35 ET

Taiko Pharmaceutical: Summary of financial results for the 1st quarter of 2024

May 10 02:30 ET

Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2024/12 (FY2024)

May 10 02:30 ET

Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

May 10 02:30 ET

Taiko Pharmaceutical: Notice regarding completion of payment of disposal of treasury stock as stock reward with transfer restrictions

Apr 19 02:30 ET

Taiko Pharmaceutical: Corporate Governance Report 2024/04/12

Apr 11 21:18 ET

Taiko Pharmaceutical: Extraordinary Report

Apr 1 02:14 ET

Taiko Pharmaceutical: Notice regarding disposal of treasury stock as share compensation with transfer restrictions

Mar 28 02:30 ET

Taiko Pharmaceutical: Internal Control Report - 78th Term (2023/01/01 - 2023/12/31)

Mar 28 02:30 ET

Taiko Pharmaceutical: Confirmation

Mar 28 02:28 ET

Taiko Pharmaceutical: Financial Report - 78th Term (2023/01/01 - 2023/12/31)

Mar 28 02:26 ET

Taiko Pharmaceutical: Plans for compliance with listing maintenance standards

Mar 19 02:30 ET

Taiko Pharmaceutical: Notice Concerning the Recording of Special Profit and Revision of Consolidated Earnings Forecasts

Mar 7 01:30 ET

Taiko Pharmaceutical: Independent Officer Registration Form

Mar 7 01:30 ET

Taiko Pharmaceutical: Notice of Convocation of 2024 Annual General Meeting of Shareholders

Mar 5 18:00 ET

Taiko Pharmaceutical: Notice regarding changes in officers

Feb 20 01:30 ET

Taiko Pharmaceutical: Notice regarding a decrease in the amount of capital (capital reduction)

Feb 20 01:30 ET

Taiko Pharmaceutical: Consolidated financial results report for the fiscal year ending 2023/12 (FY2023)

Feb 14 22:00 ET

Taiko Pharmaceutical: Extraordinary Report

Feb 9 01:36 ET